22 Healthcare Stocks Moving In Thursday's Pre-Market Session

Gainers

  • Hepion Pharmaceuticals, Inc. HEPA shares moved upwards by 53.7% to $3.72 during Thursday's pre-market session. The market cap seems to be at $10.8 million.
  • Phio Pharmaceuticals, Inc. PHIO shares surged 32.8% to $0.15. The market value of their outstanding shares is at $5.7 million.
  • Celyad, Inc. CYAD stock moved upwards by 13.8% to $12.50.
  • Enlivex Therapeutics, Inc. ENLV stock moved upwards by 10.9% to $9.18. The market cap seems to be at $68.9 million.
  • Ocugen, Inc. OCGN stock increased by 10.3% to $0.32. The market value of their outstanding shares is at $19.7 million.
  • Genprex, Inc. GNPX shares rose 8.3% to $0.38. The market value of their outstanding shares is at $7.9 million.
  • Tonix Pharmaceuticals, Inc. TNXP shares moved upwards by 7.5% to $1.57. The market value of their outstanding shares is at $4.6 million.
  • NeuBase Therapeutics, Inc. NBSE shares increased by 5.1% to $6.64. The market cap stands at $85.6 million.
  • Iovance Biotherapeutics, Inc. IOVA shares moved upwards by 4.4% to $23.98. The market cap seems to be at $2.6 billion. The most recent rating by Baird, on November 05, is at Outperform, with a price target of $60.00.
  • Aurora Cannabis, Inc. ACB shares surged 4.2% to $2.74. The market value of their outstanding shares is at $4.8 billion. The most recent rating by Piper Jaffray, on October 22, is at Neutral, with a price target of $4.00.
  • Aphria, Inc. APHA stock increased by 3.9% to $4.68. The market cap seems to be at $1.6 billion.
  • Canopy Growth, Inc. CGC stock rose 3.9% to $18.34. The market cap stands at $9.1 billion. According to the most recent rating by Bank of America, on November 20, the current rating is at Buy.
  • Tilray, Inc. TLRY shares increased by 3.7% to $21.70. The market cap stands at $2.2 billion. The most recent rating by MKM Partners, on November 14, is at Neutral, with a price target of $26.00.
  • Cronos Group, Inc. CRON shares rose 3.4% to $7.10. The market cap seems to be at $3.6 billion. The most recent rating by Bank of America, on November 13, is at Buy, with a price target of $15.00.
  • Karuna Therapeutics, Inc. KRTX shares increased by 2.9% to $112.08. The market value of their outstanding shares is at $325.9 million. The most recent rating by Goldman Sachs, on November 18, is at Buy, with a price target of $109.00.
  • Clovis Oncology, Inc. CLVS stock moved upwards by 2.7% to $7.20. The market value of their outstanding shares is at $173.7 million. The most recent rating by Evercore ISI Group, on November 19, is at In-Line, with a price target of $8.00.
  • Sanofi, Inc. SNY shares increased by 1.7% to $46.73. According to the most recent rating by Guggenheim, on September 23, the current rating is at Buy.
  • Aravive, Inc. ARAV shares rose 1.1% to $9.75. The market cap stands at $74.4 million.

 

Losers

  • Onconova Therapeutics, Inc. ONTX shares declined 7.2% to $0.28 during Thursday's pre-market session. The market value of their outstanding shares is at $4.3 million.
  • Amarin Corp, Inc. AMRN stock plummeted 2.3% to $19.80. The market cap stands at $5.8 billion. The most recent rating by Oppenheimer, on November 20, is at Underperform, with a price target of $7.00.
  • CRISPR Therapeutics, Inc. CRSP stock fell 2.1% to $66.00. The market cap stands at $2.2 billion. The most recent rating by Oppenheimer, on November 12, is at Outperform, with a price target of $65.00.
  • Grifols, Inc. GRFS shares decreased by 1.0% to $21.99. According to the most recent rating by Santander, on October 28, the current rating is at Buy.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneralHealthcare Stocks Pre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!